CLIVE ROBERTSON: Open Payments
NPI 1710655006 · BEDFORD, NH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$996 in 42 payments from 15 companies in 2025. Trend: 2023 $1,559 · 2024 $2,299 · 2025 $996
Food & beverage: $996
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $345 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $92 |
| Lundbeck LLC | 3 | $69 |
| Janssen Pharmaceuticals, Inc | 3 | $62 |
| Teva Pharmaceuticals USA, Inc. | 3 | $59 |
| SI-BONE, INC. | 1 | $56 |
| Merz Pharmaceuticals, LLC | 2 | $53 |
| Boston Scientific Corporation | 3 | $53 |
| Axsome Therapeutics, Inc. | 2 | $46 |
| PFIZER INC. | 2 | $40 |
Products named: UBRELVY, QULIPTA, RELISTOR, BOTOX, VYEPTI, SPRAVATO, AUSTEDO XR, Xeomin.
Industry payments across NH — which companies pay providers there.
